Advertisement

Evaluation of the Adnexal Mass

  • John V. Knaus
  • Kevin Ward
Chapter

Abstract

Patients found to have a pelvic adnexal mass in the ambulatory setting are most often asymptomatic or minimally symptomatic. Rather than the need for urgent surgical management which is common in patients with acute pelvic symptomatology, patients with an adnexal mass in the ambulatory setting more often require quantification of the risk of malignancy or a structured plan for surveillance (Table 8.1). Refinements in ultrasound diagnostics (adnexal mass morphology, color flow Doppler), serum tumor markers, multivariate index assays, and genetic testing, when appropriate, have all become strategic in the assessment of an adnexal mass.

Keywords

Adnexal Mass Ovarian Mass Serum Biomarkers Multivariate Index assay Ovarian Cancer Pelvic ultrasound 

References

  1. 1.
    Herman AJ, Kluivers KB, Janssen LM, et al. Adnexal masses in children, adolescents and women of reproductive age in the Netherlands: a nationwide population-based cohort study. Gynecol Oncol. 2016;143:93–7.CrossRefGoogle Scholar
  2. 2.
    Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10- year review. Obstet Gynecol. 1989;74:921–6.PubMedGoogle Scholar
  3. 3.
    Kerlikowske K, Brown JS, Grady DR. Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol. 1992;80:700–7.PubMedGoogle Scholar
  4. 4.
    van Nagell JR Jr, Miller RW, De Simone C, Ueland FR, Podzielinski I, Goodrich S, et al. Long-term survival of women with epithelial ovarian cancer detected by ultrasoungraphic screening. Obstet Gynecol. 2011;118:1212–21.CrossRefGoogle Scholar
  5. 5.
    Sharma A, Apostolidou S, Burnell M, Campbell S, Habib M, Gentry-Maharaj A, et al. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). Ultrasound Onstet Gynecol. 2012;40:338–44.CrossRefGoogle Scholar
  6. 6.
    Benacerraf BR. Ultrasonic diagnosis of ovarian masses: can the playing field be leveled and raised at the same time? Am J Obstet Gynecol. 2016;127:419–20.CrossRefGoogle Scholar
  7. 7.
    Baily CL, Ueland FR, Land GL, DePriest PD, Gallion HH, Kryscio RJ, van Nagell JR Jr. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol. 1998;69:3–7.CrossRefGoogle Scholar
  8. 8.
    Modesitt SC, Pavlik EJ, Ueland FR, van Nagell JR Jr. Risk of malignancy in unicocular ovarian cystic tumors less than 10 cm in diameter. Obstet Gynecol. 2003;102:594–9.PubMedGoogle Scholar
  9. 9.
    Saunders BA, Pidzielinski I, Ware RA, Goodrich S, DeSimone CP, Ueland FR, et al. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors. Gynecl Oncol. 2010;188:278–82.CrossRefGoogle Scholar
  10. 10.
    Timmerman D, Calster B, Testa A, et al. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the international ovarian tumor analysis group. Am J Obstet Gynecol. 2016;201:424–37.CrossRefGoogle Scholar
  11. 11.
    Van Calster B, Van Hoorde K, Froyman W, et al. Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors. Facts Views Vis Obgyn. 2015;7:32–41.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Timmerman D, Van Calster B, Jurkovic D, et al. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors. J Clin Oncol. 2007;25:4194–200.CrossRefGoogle Scholar
  13. 13.
    van Nagell JR, Miller RW Jr, et al. Evaluation and management of ultrasonographically detected ovarian tumors in asymptomatic women. Obstet Gynecol. 2016;127:848–58.CrossRefGoogle Scholar
  14. 14.
    Coleman RL, Herzog TJ, Chan DW, et al. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses. Am J Obstet Gynecol. 2016;215:e1–11.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Gynecologic OncologyPresence Saint Francis HospitalEvanstonUSA
  3. 3.Department of Obstetrics and GynecologyPresence Saint Francis HospitalEvanstonUSA

Personalised recommendations